IGF2 and prostate carcinoma: These results allow us to propose that miR-483 may be coexpressed with its host gene, IGF2. IGF2 has been reported to be involved in the development of many tumors, including Wilms' tumor, hepatocellular carcinoma, breast cancer, bladder cancer, prostate cancer, colorectal cancer, etc. [21–23].